Drugs / Cimetadine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04918914 Background | Oct 2020 → Dec 2021 | COVID-19, acute respiratory distress syndrome | Hunt Regional Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cimetadine | “Dapsone 100-200 md orally daily, along with Cimetadine 400 mg PO TID” NCT04918914 ↗ |
| Route | Oral | “Cimetadine 400 mg PO TID” NCT04918914 ↗ |